Skip to content
Sucralfate
Carafate (sucralfate) is an unknown pharmaceutical. Sucralfate was first approved as Carafate on 1982-01-01. It is used to treat duodenal ulcer, esophagitis, gastritis, pneumonia, and stomach ulcer amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
digestive system diseasesD004066
stomatognathic diseasesD009057
respiratory tract diseasesD012140
Trade Name
FDA
EMA
Carafate (generic drugs available since 1996-03-29)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sucralfate
Tradename
Company
Number
Date
Products
CARAFATEAbbVieN-018333 RX1982-01-01
1 products, RLD, RS
CARAFATEAbbVieN-019183 RX1993-12-16
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
carafateNew Drug Application2023-01-05
sucralfateANDA2015-09-30
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
duodenal ulcerEFO_0004607D004381K26
esophagitisHP_0100633D004941K20
gastritisEFO_0000217D005756K29.7
pneumoniaEFO_0003106D011014J18
stomach ulcerD013276K25
stomatitisEFO_1001904D013280K12.1
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
A02: Drugs for acid related disorders
A02B: Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BX: Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) in atc
A02BX02: Sucralfate
HCPCS
No data
Clinical
Clinical Trials
11 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pulmonary tuberculosisD014397EFO_1000049A15112
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PlagueD010930EFO_0007481A20122
Buruli ulcerD054312EFO_1001281A31.1111
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Mycobacterium avium-intracellulare infectionD015270EFO_000738611
FrailtyD000073496R53.1111
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients11
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv infectionsD015658EFO_0000764B2011
TuberculosisD014376EFO_0000774A15-A1911
Colorectal neoplasmsD01517911
Surgical wound infectionD01353011
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSUCRALFATE
INNsucralfate
Description
Sucralfate, sold under various brand names, is a medication used to treat stomach ulcers, gastroesophageal reflux disease (GERD), radiation proctitis, and stomach inflammation and to prevent stress ulcers. Its usefulness in people infected by H. pylori is limited. It is used by mouth (for upper GIT ulcers) and rectally (for radiation proctitis).
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O=S(=O)(OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O)O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O
Identifiers
PDB
CAS-ID54182-58-0
RxCUI10156
ChEMBL IDCHEMBL3989780
ChEBI ID
PubChem CID121494085
DrugBankDB00364
UNII IDXX73205DH5 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
Carafate - Allergan
$
£
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Carafate - Warner Chilcott
$
£
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 3,568 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
665 adverse events reported
View more details